Anti-inflammatory Therapeutics Industry Research Report 2023

Anti-inflammatory Therapeutics Industry Research Report 2023


Anti-inflammatory therapeutics are treatments for arthritis, respiratory diseases, dermatology, psoriasis, inflammatory bowel disease and other inflammatory diseases. The treatments include anti-inflammatory biologics, NSAIDs, corticosteroids and others.

Highlights

The global Anti-inflammatory Therapeutics market is projected to reach US$ million by 2029 from an estimated US$ million in 2023, at a CAGR of % during 2024 and 2029.
Top 5 manufacturers make up the major market share in the anti-inflammatory therapeutics market. AbbVie maintained its first place in the ranking in 2019, accounted for 21.59% market share. Other players accounted for 14.20%, 5.43%, 5.32% including Johnson & Johnson, Amgen Inc, AstraZeneca PLC.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Anti-inflammatory Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Anti-inflammatory Therapeutics.
The Anti-inflammatory Therapeutics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Anti-inflammatory Therapeutics market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Anti-inflammatory Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.

Key Companies & Market Share Insights


In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue by companies for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:

AbbVie
Johnson & Johnson
Amgen Inc
AstraZeneca PLC
Pfizer, Inc
Novartis
Roche
Merck
Sanofi
GlaxoSmithKline
Sun Pharmaceutical Industries Ltd
TEVA

Product Type Insights

Global markets are presented by Anti-inflammatory Therapeutics type, along with growth forecasts through 2029. Estimates on revenue are based on the price in the supply chain at which the Anti-inflammatory Therapeutics are procured by the companies.
This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows revenue data by type, and during the historical period (2018-2023) and forecast period (2024-2029).
Anti-inflammatory Therapeutics segment by Type

Anti-inflammatory Biologics
Non-Steroidal Anti-inflammatory Drugs (NSAIDs)
Corticosteroids
Others

Application Insights

This report has provided the market size (revenue data) by application, during the historical period (2018-2023) and forecast period (2024-2029).
This report also outlines the market trends of each segment and consumer behaviors impacting the Anti-inflammatory Therapeutics market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the Anti-inflammatory Therapeutics market.
Anti-inflammatory Therapeutics Segment by Application

Arthritis
Respiratory Diseases
Dermatology
Gastroenterology
Others

Regional Outlook

This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue data of each region and country for the period 2018-2029.
The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2022 because of the base year, with estimates for 2023 and forecast revenue for 2029.

North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Anti-inflammatory Therapeutics market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.

Reasons to Buy This Report

This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Anti-inflammatory Therapeutics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
This report will help stakeholders to understand the global industry status and trends of Anti-inflammatory Therapeutics and provides them with information on key market drivers, restraints, challenges, and opportunities.
This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
This report stays updated with novel technology integration, features, and the latest developments in the market
This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Anti-inflammatory Therapeutics industry.
This report helps stakeholders to gain insights into which regions to target globally
This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Anti-inflammatory Therapeutics.
This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Core Chapters

Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Anti-inflammatory Therapeutics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.

Frequently Asked Questions

What factors will challenge the Product Name market growth?
Which end-use segment will expand at the fastest CAGR in the Product Name market?
Which are the emerging players in the Product Name market?
How concentrated is the Product Name market?
Which factors are positively contributing to the Product Name market growth?
Which are the novel product innovations in the Product Name market?
Which product segment will emerge as the most lucrative in the Product Name market?
Which factors are increasing the competition in the Product Name market?
Which are the strategic measures taken by the Product Name industry players?
Which region will witness inactive growth during the forecast period?
What key trends are likely to emerge in the Product Name market in the coming years?


1 Preface
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 Market Overview
2.1 Product Definition
2.2 Anti-inflammatory Therapeutics by Type
2.2.1 Market Value Comparison by Type (2018 VS 2022 VS 2029)
1.2.2 Anti-inflammatory Biologics
1.2.3 Non-Steroidal Anti-inflammatory Drugs (NSAIDs)
1.2.4 Corticosteroids
1.2.5 Others
2.3 Anti-inflammatory Therapeutics by Application
2.3.1 Market Value Comparison by Application (2018 VS 2022 VS 2029)
2.3.2 Arthritis
2.3.3 Respiratory Diseases
2.3.4 Dermatology
2.3.5 Gastroenterology
2.3.6 Others
2.4 Assumptions and Limitations
3 Anti-inflammatory Therapeutics Breakdown Data by Type
3.1 Global Anti-inflammatory Therapeutics Historic Market Size by Type (2018-2023)
3.2 Global Anti-inflammatory Therapeutics Forecasted Market Size by Type (2023-2028)
4 Anti-inflammatory Therapeutics Breakdown Data by Application
4.1 Global Anti-inflammatory Therapeutics Historic Market Size by Application (2018-2023)
4.2 Global Anti-inflammatory Therapeutics Forecasted Market Size by Application (2018-2023)
5 Global Growth Trends
5.1 Global Anti-inflammatory Therapeutics Market Perspective (2018-2029)
5.2 Global Anti-inflammatory Therapeutics Growth Trends by Region
5.2.1 Global Anti-inflammatory Therapeutics Market Size by Region: 2018 VS 2022 VS 2029
5.2.2 Anti-inflammatory Therapeutics Historic Market Size by Region (2018-2023)
5.2.3 Anti-inflammatory Therapeutics Forecasted Market Size by Region (2024-2029)
5.3 Anti-inflammatory Therapeutics Market Dynamics
5.3.1 Anti-inflammatory Therapeutics Industry Trends
5.3.2 Anti-inflammatory Therapeutics Market Drivers
5.3.3 Anti-inflammatory Therapeutics Market Challenges
5.3.4 Anti-inflammatory Therapeutics Market Restraints
6 Market Competitive Landscape by Players
6.1 Global Top Anti-inflammatory Therapeutics Players by Revenue
6.1.1 Global Top Anti-inflammatory Therapeutics Players by Revenue (2018-2023)
6.1.2 Global Anti-inflammatory Therapeutics Revenue Market Share by Players (2018-2023)
6.2 Global Anti-inflammatory Therapeutics Industry Players Ranking, 2021 VS 2022 VS 2023
6.3 Global Key Players of Anti-inflammatory Therapeutics Head office and Area Served
6.4 Global Anti-inflammatory Therapeutics Players, Product Type & Application
6.5 Global Anti-inflammatory Therapeutics Players, Date of Enter into This Industry
6.6 Global Anti-inflammatory Therapeutics Market CR5 and HHI
6.7 Global Players Mergers & Acquisition
7 North America
7.1 North America Anti-inflammatory Therapeutics Market Size (2018-2029)
7.2 North America Anti-inflammatory Therapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 North America Anti-inflammatory Therapeutics Market Size by Country (2018-2023)
7.4 North America Anti-inflammatory Therapeutics Market Size by Country (2024-2029)
7.5 United States
7.6 Canada
8 Europe
8.1 Europe Anti-inflammatory Therapeutics Market Size (2018-2029)
8.2 Europe Anti-inflammatory Therapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2029
8.3 Europe Anti-inflammatory Therapeutics Market Size by Country (2018-2023)
8.4 Europe Anti-inflammatory Therapeutics Market Size by Country (2024-2029)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
9 Asia-Pacific
9.1 Asia-Pacific Anti-inflammatory Therapeutics Market Size (2018-2029)
9.2 Asia-Pacific Anti-inflammatory Therapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Asia-Pacific Anti-inflammatory Therapeutics Market Size by Country (2018-2023)
9.4 Asia-Pacific Anti-inflammatory Therapeutics Market Size by Country (2024-2029)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
10 Latin America
10.1 Latin America Anti-inflammatory Therapeutics Market Size (2018-2029)
10.2 Latin America Anti-inflammatory Therapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Latin America Anti-inflammatory Therapeutics Market Size by Country (2018-2023)
10.4 Latin America Anti-inflammatory Therapeutics Market Size by Country (2024-2029)
9.4 Mexico
9.5 Brazil
11 Middle East & Africa
11.1 Middle East & Africa Anti-inflammatory Therapeutics Market Size (2018-2029)
11.2 Middle East & Africa Anti-inflammatory Therapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2029
11.3 Middle East & Africa Anti-inflammatory Therapeutics Market Size by Country (2018-2023)
11.4 Middle East & Africa Anti-inflammatory Therapeutics Market Size by Country (2024-2029)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
12 Players Profiled
11.1 AbbVie
11.1.1 AbbVie Company Detail
11.1.2 AbbVie Business Overview
11.1.3 AbbVie Anti-inflammatory Therapeutics Introduction
11.1.4 AbbVie Revenue in Anti-inflammatory Therapeutics Business (2017-2022)
11.1.5 AbbVie Recent Development
11.2 Johnson & Johnson
11.2.1 Johnson & Johnson Company Detail
11.2.2 Johnson & Johnson Business Overview
11.2.3 Johnson & Johnson Anti-inflammatory Therapeutics Introduction
11.2.4 Johnson & Johnson Revenue in Anti-inflammatory Therapeutics Business (2017-2022)
11.2.5 Johnson & Johnson Recent Development
11.3 Amgen Inc
11.3.1 Amgen Inc Company Detail
11.3.2 Amgen Inc Business Overview
11.3.3 Amgen Inc Anti-inflammatory Therapeutics Introduction
11.3.4 Amgen Inc Revenue in Anti-inflammatory Therapeutics Business (2017-2022)
11.3.5 Amgen Inc Recent Development
11.4 AstraZeneca PLC
11.4.1 AstraZeneca PLC Company Detail
11.4.2 AstraZeneca PLC Business Overview
11.4.3 AstraZeneca PLC Anti-inflammatory Therapeutics Introduction
11.4.4 AstraZeneca PLC Revenue in Anti-inflammatory Therapeutics Business (2017-2022)
11.4.5 AstraZeneca PLC Recent Development
11.5 Pfizer, Inc
11.5.1 Pfizer, Inc Company Detail
11.5.2 Pfizer, Inc Business Overview
11.5.3 Pfizer, Inc Anti-inflammatory Therapeutics Introduction
11.5.4 Pfizer, Inc Revenue in Anti-inflammatory Therapeutics Business (2017-2022)
11.5.5 Pfizer, Inc Recent Development
11.6 Novartis
11.6.1 Novartis Company Detail
11.6.2 Novartis Business Overview
11.6.3 Novartis Anti-inflammatory Therapeutics Introduction
11.6.4 Novartis Revenue in Anti-inflammatory Therapeutics Business (2017-2022)
11.6.5 Novartis Recent Development
11.7 Roche
11.7.1 Roche Company Detail
11.7.2 Roche Business Overview
11.7.3 Roche Anti-inflammatory Therapeutics Introduction
11.7.4 Roche Revenue in Anti-inflammatory Therapeutics Business (2017-2022)
11.7.5 Roche Recent Development
11.8 Merck
11.8.1 Merck Company Detail
11.8.2 Merck Business Overview
11.8.3 Merck Anti-inflammatory Therapeutics Introduction
11.8.4 Merck Revenue in Anti-inflammatory Therapeutics Business (2017-2022)
11.8.5 Merck Recent Development
11.9 Sanofi
11.9.1 Sanofi Company Detail
11.9.2 Sanofi Business Overview
11.9.3 Sanofi Anti-inflammatory Therapeutics Introduction
11.9.4 Sanofi Revenue in Anti-inflammatory Therapeutics Business (2017-2022)
11.9.5 Sanofi Recent Development
11.10 GlaxoSmithKline
11.10.1 GlaxoSmithKline Company Detail
11.10.2 GlaxoSmithKline Business Overview
11.10.3 GlaxoSmithKline Anti-inflammatory Therapeutics Introduction
11.10.4 GlaxoSmithKline Revenue in Anti-inflammatory Therapeutics Business (2017-2022)
11.10.5 GlaxoSmithKline Recent Development
11.11 Sun Pharmaceutical Industries Ltd
11.11.1 Sun Pharmaceutical Industries Ltd Company Detail
11.11.2 Sun Pharmaceutical Industries Ltd Business Overview
11.11.3 Sun Pharmaceutical Industries Ltd Anti-inflammatory Therapeutics Introduction
11.11.4 Sun Pharmaceutical Industries Ltd Revenue in Anti-inflammatory Therapeutics Business (2017-2022)
11.11.5 Sun Pharmaceutical Industries Ltd Recent Development
11.12 TEVA
11.12.1 TEVA Company Detail
11.12.2 TEVA Business Overview
11.12.3 TEVA Anti-inflammatory Therapeutics Introduction
11.12.4 TEVA Revenue in Anti-inflammatory Therapeutics Business (2017-2022)
11.12.5 TEVA Recent Development
13 Report Conclusion
14 Disclaimer
List of Tables
Table 1. Secondary Sources
Table 2. Primary Sources
Table 3. Market Value Comparison by Type (2018 VS 2022 VS 2029) & (US$ Million)
Table 4. Market Value Comparison by Application (2018 VS 2022 VS 2029) & (US$ Million)
Table 5. Global Anti-inflammatory Therapeutics Market Size by Type (2018-2023) & (US$ Million)
Table 6. Global Anti-inflammatory Therapeutics Revenue Market Share by Type (2018-2023)
Table 7. Global Anti-inflammatory Therapeutics Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 8. Global Anti-inflammatory Therapeutics Revenue Market Share by Type (2024-2029)
Table 9. Global Anti-inflammatory Therapeutics Market Size by Application (2018-2023) & (US$ Million)
Table 10. Global Anti-inflammatory Therapeutics Revenue Market Share by Application (2018-2023)
Table 11. Global Anti-inflammatory Therapeutics Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 12. Global Anti-inflammatory Therapeutics Revenue Market Share by Application (2024-2029)
Table 13. Global Anti-inflammatory Therapeutics Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 14. Global Anti-inflammatory Therapeutics Market Size by Region (2018-2023) & (US$ Million)
Table 15. Global Anti-inflammatory Therapeutics Market Share by Region (2018-2023)
Table 16. Global Anti-inflammatory Therapeutics Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 17. Global Anti-inflammatory Therapeutics Market Share by Region (2024-2029)
Table 18. Anti-inflammatory Therapeutics Market Trends
Table 19. Anti-inflammatory Therapeutics Market Drivers
Table 20. Anti-inflammatory Therapeutics Market Challenges
Table 21. Anti-inflammatory Therapeutics Market Restraints
Table 22. Global Top Anti-inflammatory Therapeutics Manufacturers by Revenue (US$ Million) & (2018-2023)
Table 23. Global Anti-inflammatory Therapeutics Revenue Market Share by Manufacturers (2018-2023)
Table 24. Global Anti-inflammatory Therapeutics Industry Manufacturers Ranking, 2021 VS 2022 VS 2023
Table 25. Global Key Players of Anti-inflammatory Therapeutics, Headquarters and Area Served
Table 26. Global Anti-inflammatory Therapeutics Manufacturers, Product Type & Application
Table 27. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 28. Global Anti-inflammatory Therapeutics by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2022)
Table 29. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 30. North America Anti-inflammatory Therapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. North America Anti-inflammatory Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 32. North America Anti-inflammatory Therapeutics Market Size by Country (2024-2029) & (US$ Million)
Table 33. Europe Anti-inflammatory Therapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 34. Europe Anti-inflammatory Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 35. Europe Anti-inflammatory Therapeutics Market Size by Country (2024-2029) & (US$ Million)
Table 36. Asia-Pacific Anti-inflammatory Therapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 37. Asia-Pacific Anti-inflammatory Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 38. Asia-Pacific Anti-inflammatory Therapeutics Market Size by Country (2024-2029) & (US$ Million)
Table 39. Latin America Anti-inflammatory Therapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 40. Latin America Anti-inflammatory Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 41. Latin America Anti-inflammatory Therapeutics Market Size by Country (2024-2029) & (US$ Million)
Table 42. Middle East & Africa Anti-inflammatory Therapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 43. Middle East & Africa Anti-inflammatory Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 44. Middle East & Africa Anti-inflammatory Therapeutics Market Size by Country (2024-2029) & (US$ Million)
Table 45. AbbVie Company Detail
Table 46. AbbVie Business Overview
Table 47. AbbVie Anti-inflammatory Therapeutics Product
Table 48. AbbVie Revenue in Anti-inflammatory Therapeutics Business (2017-2022) & (US$ Million)
Table 49. AbbVie Recent Development
Table 50. Johnson & Johnson Company Detail
Table 51. Johnson & Johnson Business Overview
Table 52. Johnson & Johnson Anti-inflammatory Therapeutics Product
Table 53. Johnson & Johnson Revenue in Anti-inflammatory Therapeutics Business (2017-2022) & (US$ Million)
Table 54. Johnson & Johnson Recent Development
Table 55. Amgen Inc Company Detail
Table 56. Amgen Inc Business Overview
Table 57. Amgen Inc Anti-inflammatory Therapeutics Product
Table 58. Amgen Inc Revenue in Anti-inflammatory Therapeutics Business (2017-2022) & (US$ Million)
Table 59. Amgen Inc Recent Development
Table 60. AstraZeneca PLC Company Detail
Table 61. AstraZeneca PLC Business Overview
Table 62. AstraZeneca PLC Anti-inflammatory Therapeutics Product
Table 63. AstraZeneca PLC Revenue in Anti-inflammatory Therapeutics Business (2017-2022) & (US$ Million)
Table 64. AstraZeneca PLC Recent Development
Table 65. Pfizer, Inc Company Detail
Table 66. Pfizer, Inc Business Overview
Table 67. Pfizer, Inc Anti-inflammatory Therapeutics Product
Table 68. Pfizer, Inc Revenue in Anti-inflammatory Therapeutics Business (2017-2022) & (US$ Million)
Table 69. Pfizer, Inc Recent Development
Table 70. Novartis Company Detail
Table 71. Novartis Business Overview
Table 72. Novartis Anti-inflammatory Therapeutics Product
Table 73. Novartis Revenue in Anti-inflammatory Therapeutics Business (2017-2022) & (US$ Million)
Table 74. Novartis Recent Development
Table 75. Roche Company Detail
Table 76. Roche Business Overview
Table 77. Roche Anti-inflammatory Therapeutics Product
Table 78. Roche Revenue in Anti-inflammatory Therapeutics Business (2017-2022) & (US$ Million)
Table 79. Roche Recent Development
Table 80. Merck Company Detail
Table 81. Merck Business Overview
Table 82. Merck Anti-inflammatory Therapeutics Product
Table 83. Merck Revenue in Anti-inflammatory Therapeutics Business (2017-2022) & (US$ Million)
Table 84. Merck Recent Development
Table 85. Sanofi Company Detail
Table 86. Sanofi Business Overview
Table 87. Sanofi Anti-inflammatory Therapeutics Product
Table 88. Sanofi Revenue in Anti-inflammatory Therapeutics Business (2017-2022) & (US$ Million)
Table 89. Sanofi Recent Development
Table 90. GlaxoSmithKline Company Detail
Table 91. GlaxoSmithKline Business Overview
Table 92. GlaxoSmithKline Anti-inflammatory Therapeutics Product
Table 93. GlaxoSmithKline Revenue in Anti-inflammatory Therapeutics Business (2017-2022) & (US$ Million)
Table 94. GlaxoSmithKline Recent Development
Table 95. Sun Pharmaceutical Industries Ltd Company Detail
Table 96. Sun Pharmaceutical Industries Ltd Business Overview
Table 97. Sun Pharmaceutical Industries Ltd Anti-inflammatory TherapeuticsProduct
Table 98. Sun Pharmaceutical Industries Ltd Revenue in Anti-inflammatory Therapeutics Business (2017-2022) & (US$ Million)
Table 99. Sun Pharmaceutical Industries Ltd Recent Development
Table 100. TEVA Company Detail
Table 101. TEVA Business Overview
Table 102. TEVA Anti-inflammatory TherapeuticsProduct
Table 103. TEVA Revenue in Anti-inflammatory Therapeutics Business (2017-2022) & (US$ Million)
Table 104. TEVA Recent Development
Table 105. AbbVie Company Information
Table 106. AbbVie Business Overview
Table 107. AbbVie Anti-inflammatory Therapeutics Revenue in Anti-inflammatory Therapeutics Business (2018-2023) & (US$ Million)
Table 108. AbbVie Revenue in Anti-inflammatory Therapeutics Business (2018-2023) & (US$ Million) Portfolio
Table 109. AbbVie Recent Development
Table 110. Johnson & Johnson Company Information
Table 111. Johnson & Johnson Business Overview
Table 112. Johnson & Johnson Anti-inflammatory Therapeutics Revenue in Anti-inflammatory Therapeutics Business (2018-2023) & (US$ Million)
Table 113. Johnson & Johnson Revenue in Anti-inflammatory Therapeutics Business (2018-2023) & (US$ Million) Portfolio
Table 114. Johnson & Johnson Recent Development
Table 115. Amgen Inc Company Information
Table 116. Amgen Inc Business Overview
Table 117. Amgen Inc Anti-inflammatory Therapeutics Revenue in Anti-inflammatory Therapeutics Business (2018-2023) & (US$ Million)
Table 118. Amgen Inc Revenue in Anti-inflammatory Therapeutics Business (2018-2023) & (US$ Million) Portfolio
Table 119. Amgen Inc Recent Development
Table 120. AstraZeneca PLC Company Information
Table 121. AstraZeneca PLC Business Overview
Table 122. AstraZeneca PLC Anti-inflammatory Therapeutics Revenue in Anti-inflammatory Therapeutics Business (2018-2023) & (US$ Million)
Table 123. AstraZeneca PLC Revenue in Anti-inflammatory Therapeutics Business (2018-2023) & (US$ Million) Portfolio
Table 124. AstraZeneca PLC Recent Development
Table 125. Pfizer, Inc Company Information
Table 126. Pfizer, Inc Business Overview
Table 127. Pfizer, Inc Anti-inflammatory Therapeutics Revenue in Anti-inflammatory Therapeutics Business (2018-2023) & (US$ Million)
Table 128. Pfizer, Inc Revenue in Anti-inflammatory Therapeutics Business (2018-2023) & (US$ Million) Portfolio
Table 129. Pfizer, Inc Recent Development
Table 130. Novartis Company Information
Table 131. Novartis Business Overview
Table 132. Novartis Anti-inflammatory Therapeutics Revenue in Anti-inflammatory Therapeutics Business (2018-2023) & (US$ Million)
Table 133. Novartis Revenue in Anti-inflammatory Therapeutics Business (2018-2023) & (US$ Million) Portfolio
Table 134. Novartis Recent Development
Table 135. Roche Company Information
Table 136. Roche Business Overview
Table 137. Roche Anti-inflammatory Therapeutics Revenue in Anti-inflammatory Therapeutics Business (2018-2023) & (US$ Million)
Table 138. Roche Revenue in Anti-inflammatory Therapeutics Business (2018-2023) & (US$ Million) Portfolio
Table 139. Roche Recent Development
Table 140. Merck Company Information
Table 141. Merck Business Overview
Table 142. Merck Anti-inflammatory Therapeutics Revenue in Anti-inflammatory Therapeutics Business (2018-2023) & (US$ Million)
Table 143. Merck Revenue in Anti-inflammatory Therapeutics Business (2018-2023) & (US$ Million) Portfolio
Table 144. Merck Recent Development
Table 145. Sanofi Company Information
Table 146. Sanofi Business Overview
Table 147. Sanofi Anti-inflammatory Therapeutics Revenue in Anti-inflammatory Therapeutics Business (2018-2023) & (US$ Million)
Table 148. Sanofi Revenue in Anti-inflammatory Therapeutics Business (2018-2023) & (US$ Million) Portfolio
Table 149. Sanofi Recent Development
Table 150. GlaxoSmithKline Company Information
Table 151. GlaxoSmithKline Business Overview
Table 152. GlaxoSmithKline Anti-inflammatory Therapeutics Revenue in Anti-inflammatory Therapeutics Business (2018-2023) & (US$ Million)
Table 153. GlaxoSmithKline Revenue in Anti-inflammatory Therapeutics Business (2018-2023) & (US$ Million) Portfolio
Table 154. GlaxoSmithKline Recent Development
Table 155. Sun Pharmaceutical Industries Ltd Company Information
Table 156. Sun Pharmaceutical Industries Ltd Business Overview
Table 157. Sun Pharmaceutical Industries Ltd Anti-inflammatory TherapeuticsRevenue in Anti-inflammatory Therapeutics Business (2018-2023) & (US$ Million)
Table 158. Sun Pharmaceutical Industries Ltd Revenue in Anti-inflammatory Therapeutics Business (2018-2023) & (US$ Million) Portfolio
Table 159. Sun Pharmaceutical Industries Ltd Recent Development
Table 160. TEVA Company Information
Table 161. TEVA Business Overview
Table 162. TEVA Anti-inflammatory TherapeuticsRevenue in Anti-inflammatory Therapeutics Business (2018-2023) & (US$ Million)
Table 163. TEVA Revenue in Anti-inflammatory Therapeutics Business (2018-2023) & (US$ Million) Portfolio
Table 164. TEVA Recent Development
Table 165. Authors List of This Report
List of Figures
Figure 1. Research Methodology
Figure 2. Research Process
Figure 3. Key Executives Interviewed
Figure 4. Anti-inflammatory Therapeutics Product Picture
Figure 5. Global Anti-inflammatory Therapeutics Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 6. Global Anti-inflammatory Therapeutics Market Share by Type: 2022 VS 2029
Figure 7. Anti-inflammatory Biologics Product Picture
Figure 8. Non-Steroidal Anti-inflammatory Drugs (NSAIDs) Product Picture
Figure 9. Corticosteroids Product Picture
Figure 10. Others Product Picture
Figure 11. Global Anti-inflammatory Therapeutics Market Size by Application (2023-2029) & (US$ Million)
Figure 12. Global Anti-inflammatory Therapeutics Market Share by Application: 2022 VS 2029
Figure 13. Arthritis Product Picture
Figure 14. Respiratory Diseases Product Picture
Figure 15. Dermatology Product Picture
Figure 16. Gastroenterology Product Picture
Figure 17. Others Product Picture
Figure 18. Global Anti-inflammatory Therapeutics Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 19. Global Anti-inflammatory Therapeutics Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 20. Global Anti-inflammatory Therapeutics Market Share by Region: 2022 VS 2029
Figure 21. Global Anti-inflammatory Therapeutics Market Share by Players in 2022
Figure 22. Global Anti-inflammatory Therapeutics Players, Date of Enter into This Industry
Figure 23. Global Top 5 and 10 Anti-inflammatory Therapeutics Players Market Share by Revenue in 2022
Figure 24. Players Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 25. North America Anti-inflammatory Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. North America Anti-inflammatory Therapeutics Market Share by Country (2018-2029)
Figure 27. United States Anti-inflammatory Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Canada Anti-inflammatory Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Europe Anti-inflammatory Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Europe Anti-inflammatory Therapeutics Market Share by Country (2018-2029)
Figure 31. Germany Anti-inflammatory Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. France Anti-inflammatory Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. U.K. Anti-inflammatory Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Italy Anti-inflammatory Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. Russia Anti-inflammatory Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Nordic Countries Anti-inflammatory Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Asia-Pacific Anti-inflammatory Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Asia-Pacific Anti-inflammatory Therapeutics Market Share by Country (2018-2029)
Figure 39. China Anti-inflammatory Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Japan Anti-inflammatory Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. South Korea Anti-inflammatory Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Southeast Asia Anti-inflammatory Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. India Anti-inflammatory Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Australia Anti-inflammatory Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Latin America Anti-inflammatory Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Latin America Anti-inflammatory Therapeutics Market Share by Country (2018-2029)
Figure 47. Mexico Anti-inflammatory Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 48. Brazil Anti-inflammatory Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 49. Middle East & Africa Anti-inflammatory Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 50. Middle East & Africa Anti-inflammatory Therapeutics Market Share by Country (2018-2029)
Figure 51. Turkey Anti-inflammatory Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 52. Saudi Arabia Anti-inflammatory Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 53. UAE Anti-inflammatory Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 54. AbbVie Revenue Growth Rate in Anti-inflammatory Therapeutics Business (2018-2023)
Figure 55. Johnson & Johnson Revenue Growth Rate in Anti-inflammatory Therapeutics Business (2018-2023)
Figure 56. Amgen Inc Revenue Growth Rate in Anti-inflammatory Therapeutics Business (2018-2023)
Figure 57. AstraZeneca PLC Revenue Growth Rate in Anti-inflammatory Therapeutics Business (2018-2023)
Figure 58. Pfizer, Inc Revenue Growth Rate in Anti-inflammatory Therapeutics Business (2018-2023)
Figure 59. Novartis Revenue Growth Rate in Anti-inflammatory Therapeutics Business (2018-2023)
Figure 60. Roche Revenue Growth Rate in Anti-inflammatory Therapeutics Business (2018-2023)
Figure 61. Merck Revenue Growth Rate in Anti-inflammatory Therapeutics Business (2018-2023)
Figure 62. Sanofi Revenue Growth Rate in Anti-inflammatory Therapeutics Business (2018-2023)
Figure 63. GlaxoSmithKline Revenue Growth Rate in Anti-inflammatory Therapeutics Business (2018-2023)
Figure 64. Sun Pharmaceutical Industries Ltd Revenue Growth Rate in Anti-inflammatory Therapeutics Business (2018-2023)
Figure 65. TEVA Revenue Growth Rate in Anti-inflammatory Therapeutics Business (2018-2023)

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings